Pfizer Inc.
Updated Jul 26, 2026
Depo-Provera Brain Tumor Lawsuit Update
The TapClaim listing is closed, but Depo-Provera lawsuits over alleged meningioma risk continue. No nationwide settlement or public claim form exists.
Key facts
- Claim deadline
- TBD
- Potential payment
- Payment varies
- Proof requirement
- No proof
- Status
- Closed
Eligibility
Who may qualify?
Check the covered dates, products, locations, and other official terms before you file.
- You used the Depo-Provera birth control shot.
- You received two or more Depo-Provera shots.
- You developed a meningioma or other tumor after October 2021.
- You developed the meningioma or other tumor after you took Depo-Provera shots.
Case overview
What this settlement is about
This is an ongoing product‑liability / personal‑injury arbitration and litigation matter, not a finalized settlement program. Plaintiffs allege that long‑term use of Depo‑Provera (medroxyprogesterone acetate contraceptive injections) significantly increases the risk of intracranial meningioma brain tumors, and that Pfizer failed to adequately warn patients and doctors despite emerging scientific evidence and earlier foreign label changes.



